Abstract
The cardiovascular manifestations associated with nontraumatic head disorders are commonly known. Similar manifestations have been reported in patients with traumatic brain injury (TBI); however, the underlying mechanisms and impact on the patient's clinical outcomes are not well explored. The neurocardiac axis theory and neurogenic stunned myocardium phenomenon could partly explain the brain-heart link and interactions and can thus pave the way to a better understanding and management of TBI. Several observational retrospective studies have shown a promising role for beta-adrenergic blockers in patients with TBI in reducing the overall TBI-related mortality. However, several questions remain to be answered in clinical randomized-controlled trials, including population selection, beta blocker type, dosage, timing, and duration of therapy, while maintaining the optimal mean arterial pressure and cerebral perfusion pressure in patients with TBI.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 279-288 |
| Number of pages | 10 |
| Journal | Cardiology in review |
| Volume | 25 |
| Issue number | 6 |
| DOIs | |
| State | Published - 2017 |
Keywords
- beta adrenergic blockers
- biomarkers
- brain injury
- catecholamines
- myocardial dysfunction
- neurocardiac axis
- neurogenic stunned myocardium
- trauma
- troponins
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Brain-Heart Interactions in Traumatic Brain Injury'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS